MediMix aims to bring high value medical information to Belgian healthcare professionals via multiple channels. Our team covers congresses and symposia all over the world, particularly in the hematology domain. In collaboration with Belgian and international experts, we bring the newest data to Belgian physicians.
In this video, Prof Meera Mohan, haematologist at the Medical College of Wisconsin in Milwaukee (WI, USA) discusses the highlights of an oral abstract session at ASH 2024 dedicated to
In this video, Dr Nikki Granacher, haematologist at the Ziekenhuis aan de Stroom in Antwerp talks us through her highlights from ASH 2024 related to myeloproliferative neoplasms (MPN).
Dr Muhamed Baljevic is a haematologist at the Vanderbilt University Medical Center, in Nashville, Tennessee (USA). In this vide, he discusses the results of a phase 1b study evaluating different
Prof Cédric Hermans is the head of the haematology department at the Cliniques Universitaires St.-Luc in Brussels (Belgium). During ASH 2024 he presented the patient-reported outcomes for patients treated with
During ASH 2024, Dr Johannes Duell from the University of Würzburg (Germany) presented a poster evaluating the CD19 expression before and after treatment with tafasitamab-lenalidomide in patients with relapsed/refractory diffuse
During ASH 2024, Dr Kim Saverno from the Incyte Corporation (Wilmington, DE, USA) presented real-life data with tafa-len in a cohort of 181 R/R DLBCL patients treated with this regimen
During ASH 2024, Prof Dr Antonio Gutierrez (University Hospital Son Espases, Palma de Mallorca, Spain) presented updated results of the GELTAMO study evaluating the real-life efficacy and safety of tafa-len
Dr Muhamed Baljevic is a haematologist at the Vanderbilt University Medical Center, in Nashville, Tennessee (USA). During ASH 2024 he presented data from a phase 1b/2 study evaluating the combination
